New therapeutics targeting colon cancer stem cells

Current Colorectal Cancer Reports

Volumn 5, Issue 4, 2009, Pages 209-216

  Thenappan, Arun ^a   Li, Ying ^a   Shetty, Kirti ^a   Johnson, Lynt ^a   Reddy, E P ^a   Mishra, Lopa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CELL MARKER; FLUOROURACIL; GLYCOGEN SYNTHASE KINASE 3BETA; OXALIPLATIN; SMAD4 PROTEIN; SPECTRIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STEM CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; COLORECTAL CANCER; FEEDBACK SYSTEM; HUMAN; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE;

EID: 77955074366     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-009-0029-2     Document Type: Review

References (60)

1. National Cancer Institute: Colon cancer treatment (PDQ). Available at http://www.cancer.gov/cancertopics/pdq/treatment/colon/healthprofessional/. Accessed July 2009.
2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M: Cancer statistics, 2001. CA Cancer J Clin 2001, 51:15-36.
3. Vogelstein B, Fearon ER, Hamilton SR, et al.: Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-532.
4. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
5. Huang EH, Wicha MS: Colon cancer stem cells: implications for prevention and therapy. Trends Mol Med 2008, 14:503-509. This is an excellent review of the colon cancer stem cell model and hypotheses of potential targets.
6. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170. (Pubitemid 26358996)
7. Crosnier C, Stamataki D, Lewis J: Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat Rev Genet 2006, 7:349-359.
8. van Es JH, van Gijn ME, Riccio O, et al.: Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005, 435:959-963. (Pubitemid 40896322)
9. Batlle E, Henderson JT, Beghtel H, et al.: Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002, 111:251-263. (Pubitemid 35292445)
10. Cheng H, Leblond CP: Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat 1974, 141:537-561.
11. Kirkland SC: Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium. Cancer 1988, 61:1359-1363.
12. Humphries A, Wright NA: Colonic crypt organization and tumorigenesis. Nat Rev Cancer 2008, 8:415-424. (Pubitemid 351744961)
13. Nishimura S, Wakabayashi N, Toyoda K, et al.: Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci 2003, 48:1523-1529. (Pubitemid 36936688)
14. Dekaney CM, Rodriguez JM, Graul MC, Henning SJ: Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum. Gastroenterology 2005, 129:1567-1580. (Pubitemid 41597397)
15. May R, Riehl TE, Hunt C, et al.: Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 2008, 26:630-637.
16. Holmberg J, Genander M, Halford MM, et al.: EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell 2006, 125:1151-1163. (Pubitemid 43866196)
17. Barker N, van Es JH, Kuipers J, et al.: Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007. This study demonstrates Lgr5, an intestinal Wnt target gene, is a potential colonic stem cell marker.
18. van de Wetering M, Sancho E, Verweij C, et al.: The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111:241-250. (Pubitemid 35292444)
19. Haegebarth A, Clevers H: Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol 2009, 174:715-721.
20. Singh SK, Clarke ID, Hide T, Dirks PB: Cancer stem cells in nervous system tumors. Oncogene 2004, 23:7267-7273. (Pubitemid 39382160)
21. Collins AT, Berry PA, Hyde C, et al.: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951. (Pubitemid 41713363)
22. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al.: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100:3983-3988. (Pubitemid 36418143)
23. Li C, Heidt DG, Dalerba P, et al.: Identification of pancreatic cancer stem cells. Cancer Res 2007, 67:1030-1037.
24. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737. (Pubitemid 27298715)
25. Dalerba P, Dylla SJ, Park IK, et al.: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 2007, 104:10158-10163. This study demonstrates the potential of CD44 and ESA as colon cancer stem cell markers using fluorescence-activated cell sorting for these enriched cells from tumor specimens. Injecting a few of these cells into NOD/SCID mice reconstituted a phenotypically similar tumor.
26. + cells using fluorescence-activated cell sorting from colon cancer specimens. Injecting a few of these cells into NOD/SCID mice reconstituted a phenotypically similar tumor.
27. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al.: Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115. This study also enriched CD133+ cells from colon cancer specimens and demonstrated maintenance of these cells in vitro.
28. Ieta K, Tanaka F, Haraguchi N, et al.: Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol 2008, 15:638-648. (Pubitemid 351643025)
29. Shmelkov SV, Butler JM, Hooper AT, et al.: CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008, 118:2111-2120. This study raised doubts about the specificity of CD133 as a marker of colon cancer stem cells. CD133 high- and low-expressing cells generated tumors in NOD/SCID mice.
30. Reya T, Clevers H: Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850. (Pubitemid 40558990)
31. Kohn AD, Moon RT: Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 2005, 38:439-446. (Pubitemid 41283282)
32. He TC, Sparks AB, Rago C, et al.: Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512. (Pubitemid 28425575)
33. Pecina-Slaus N: Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int 2003, 3:17.
34. Whitfield JF: Calcium, calcium-sensing receptor and colon cancer. Cancer Lett 2009, 275:9-16.
35. Pinto D, Gregorieff A, Begthel H, Clevers H: Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 2003, 17:1709-1713. (Pubitemid 36870334)
36. Gregorieff A, Pinto D, Begthel H, et al.: Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 2005, 129:626-638. (Pubitemid 41096648)
37. Preston SL, Wong WM, Chan AO, et al.: Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 2003, 63:3819-3825. (Pubitemid 36793072)
38. Boman BM, Fields JZ, Cavanaugh KL, et al.: How dysregulated colonic crypt dynamics cause stem cell overpopulation and initiate colon cancer. Cancer Res 2008, 68:3304-3313.
39. Massague J, Blain SW, Lo RS: TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
40. Boman BM, Huang E: Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 2008, 26:2828-2838. Excellent review of the colon cancer stem cell model including new markers and its role in the development of colon cancer from hereditary and inflammatory mechanisms.
41. Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700. (Pubitemid 36724933)
42. Tsukazaki T, Chiang TA, Davison AF, et al.: SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 1998, 95:779-791. (Pubitemid 29014458)
43. Tang Y, Katuri V, Dillner A, et al.: Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science 2003, 299:574-577. (Pubitemid 36135157)
44. Hoosein NM, McKnight MK, Levine AE, et al.: Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp Cell Res 1989, 181:442-453. (Pubitemid 19096410)
45. Ilyas M, Efstathiou JA, Straub J, et al.: Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression. Proc Natl Acad Sci U S A 1999, 96:3087-3091. (Pubitemid 29148848)
46. Takayama T, Miyanishi K, Hayashi T, et al.: Colorectal cancer: genetics of development and metastasis. J Gastroenterol 2006, 41:185-192.
47. Xu Y, Pasche B: TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007, 16 Spec No 1:R14-R20. (Pubitemid 47241839)
48. Thiagalingam S, Lengauer C, Leach FS, et al.: Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996, 13:343-346. (Pubitemid 26230501)
49. Tang Y, Katuri V, Srinivasan R, et al.: Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Res 2005, 65:4228-4237. (Pubitemid 40775661)
50. Mishra L, Derynck R, Mishra B: Transforming growth factor-beta signaling in stem cells and cancer. Science 2005, 310:68-71. (Pubitemid 41434534)
51. Barnard JA, Beauchamp RD, Coffey RJ, Moses HL: Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci U S A 1989, 86:1578-1582. (Pubitemid 19078946)
52. Takaku K, Oshima M, Miyoshi H, et al.: Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998, 92:645-656. (Pubitemid 28141513)
53. Alberici P, Jagmohan-Changur S, De Pater E, et al.: Smad4 haploinsufficiency in mouse models for intestinal cancer. Oncogene 2006, 25:1841-1851.
54. Munoz NM, Upton M, Rojas A, et al.: Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res 2006, 66:9837-9844. (Pubitemid 44672034)
55. Jin L, Hope KJ, Zhai Q, et al.: Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006, 12:1167-1174. (Pubitemid 44527352)
56. Todaro M, Alea MP, Di Stefano AB, et al.: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007, 1:389-402. This excellent review demonstrates the key role of IL-4 in tumorigenic growth and its targeting via a specific antibody as a means of decreasing colon cancer tumor progression.
57. Francipane MG, Alea MP, Lombardo Y, et al.: Crucial role of interleukin-4 in the survival of colon cancer stem cells. Cancer Res 2008, 68:4022-4025.
58. Dallas NA, Xia L, Fan F, et al.: Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 2009, 69:1951-1957.
59. Boman BM, Wicha MS, Fields JZ, Runquist OA: Symmetric division of cancer stem cells: a key mechanism in tumor growth that should be targeted in future therapeutic approaches. Clin Pharmacol Ther 2007, 81:893-898. This interesting review hypothesizes the specific targeting of symmetric cell division as a means of decreasing the exponential clonal growth of colonic tumors.
60. Li L, Neaves WB: Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006, 66:4553-4557.